The minimally—or non-invasive detection of circulating tumor-derived components in
biofluids, such as blood, liquid biopsy is a revolutionary approach with significant potential …

Esophageal cancer (EC) is the deadliest cancer worldwide, with a 92% annual mortality rate
per incidence. Esophageal squamous cell carcinoma (ESCC) and esophageal …

PURPOSE Circulating tumor DNA (ctDNA) analyses allow for postoperative risk stratification
in patients with curatively treated colon and breast cancers. Use of ctDNA in …

Cancer has become a global health issue and liquid biopsy has emerged as a non-invasive
tool for various applications. In cancer, circulating tumor DNA (ctDNA) can be detected from …

Abstract Background Circulating tumor DNA (ctDNA) has predictive and prognostic value in
localized and metastatic cancer. This study analyzed the prognostic value of baseline and …

Late detection and lack of precision diagnostics are the major challenges in cancer
prevention and management. Biomarker discovery in specific cancers, especially at the pre …

Aim Lung cancer screening reduces mortality. We aim to validate the performance of Lung
EpiCheck, a six-marker panel methylation-based plasma test, in the detection of lung cancer …

Simple Summary The standard of care for patients diagnosed with locally advanced
esophageal cancer is neoadjuvant chemoradiotherapy followed by surgery. There is a high …

Background To guide appropriate treatment strategy, an accurate tumor monitoring modality
that reflects tumor burden during neoadjuvant treatment is required for esophageal …

Adenocarcinoma of the oesophagus and gastro-oesophageal junction represent a large
burden of cancer death in the Western World with an increasing incidence. In the past two …